BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24132826)

  • 21. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
    Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
    Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.
    Chen JS; Wang Q; Chen XL; Huang XH; Liang LJ; Lei J; Huang JQ; Li DM; Cheng ZX
    J Surg Res; 2012 Jun; 175(2):243-50. PubMed ID: 21601221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein.
    Ban D; Shimada K; Yamamoto Y; Nara S; Esaki M; Sakamoto Y; Kosuge T
    J Gastrointest Surg; 2009 Nov; 13(11):1921-8. PubMed ID: 19727969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving outcomes of liver resection for hepatocellular carcinoma associated with portal vein tumor thrombosis over the evolving eras of treatment.
    Wang YC; Lee JC; Wu TH; Cheng CH; Lee CF; Wu TJ; Chou HS; Chan KM; Lee WC
    World J Surg Oncol; 2021 Oct; 19(1):313. PubMed ID: 34702312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of three-dimensional imaging in optimizing diagnosis, classification and surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Wei XB; Xu J; Li N; Yu Y; Shi J; Guo WX; Cheng HY; Wu MC; Lau WY; Cheng SQ
    HPB (Oxford); 2016 Mar; 18(3):287-95. PubMed ID: 27017169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of survival and quality of life of hepatectomy and thrombectomy using total hepatic vascular exclusion and chemotherapy alone in patients with hepatocellular carcinoma and tumor thrombi in the inferior vena cava and hepatic vein.
    Liu J; Wang Y; Zhang D; Liu B; Ou Q
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):186-94. PubMed ID: 22081008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomogram predicting survival of hepatocellular carcinoma with portal vein tumour thrombus after curative resection.
    Hu Y; You S; Yang Z; Cheng S
    ANZ J Surg; 2019 Jan; 89(1-2):E20-E25. PubMed ID: 30117625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis.
    Zhang YF; Le Y; Wei W; Zou RH; Wang JH; OuYang HY; Xiao CZ; Zhong XP; Shi M; Guo RP
    Oncotarget; 2016 Jun; 7(25):38845-38856. PubMed ID: 27072577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
    Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of cystoscope in surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Li N; Wei XB; Cheng SQ
    World J Gastroenterol; 2016 Jun; 22(22):5297-300. PubMed ID: 27298574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Liang L; Chen TH; Li C; Xing H; Han J; Wang MD; Zhang H; Lau WY; Wu MC; Shen F; Yang T
    HPB (Oxford); 2018 Dec; 20(12):1119-1129. PubMed ID: 30056066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic Resection for Hepatocellular Carcinoma with Tumor Thrombus in the Major Portal Vein.
    Kojima H; Hatano E; Taura K; Seo S; Yasuchika K; Uemoto S
    Dig Surg; 2015; 32(6):413-20. PubMed ID: 26316188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study.
    Kawai T; Yashima Y; Sugimoto T; Sato T; Kanda M; Enomoto N; Sato S; Obi S
    World J Surg Oncol; 2016 Feb; 14():52. PubMed ID: 26911980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between laparoscopic liver resection and open liver resection in patients with hepatocellular carcinoma with portal vein tumor thrombosis.
    Kim KS; Choi GS; Rhu J; Kim J
    Surg Endosc; 2024 Apr; 38(4):2116-2123. PubMed ID: 38438678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes.
    Chen XP; Huang ZY
    Langenbecks Arch Surg; 2005 Jun; 390(3):259-65. PubMed ID: 15875211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus.
    Song X; He Y; Liang H; Han M; Shao Z
    BMC Surg; 2020 Aug; 20(1):174. PubMed ID: 32738882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus.
    Lin DX; Zhang QY; Li X; Ye QW; Lin F; Li LL
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):139-49. PubMed ID: 20340033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors.
    Jiao T; Tang H; Zhang W; Hu B; Wan T; Cao Y; Zhang Z; Wang Y; Cao J; Cui M; Lu S
    BMC Surg; 2023 Dec; 23(1):384. PubMed ID: 38114938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Favorable Prognostic Factors for Survival Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis After Hepatectomy.
    Kim SH; Moon DB; Park YH; Lee SG; Kim KH; Hwang S; Ahn CS; Ha TY; Song GW; Jung DH; Park GC; Kim M; Na BG; Yang G; Kim SM; Oh RK
    Ann Surg Oncol; 2023 Jul; 30(7):4279-4289. PubMed ID: 37043034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.